BACKGROUND: There is a variable degree of accuracy in discriminating benign from malignant soft tissue masses based on signal intensity and morphologic characteristics by magnetic resonance imaging (MRI). The aim of this study was to determine the utility of detailed component pattern assessment, in addition to morphologic study, for differentiating benign from malignant soft tissue masses by MRI. METHODS: The imaging features of 118 histologically proven soft tissue masses were analyzed according to: (1) signal characteristics: (a) high T1 matrix; (b) low T2 matrix; (c) fibrous tissue signal; (d) calcification; (e) myxoid signal tissue; (f) fatty signal tissue; (g) cystic signal; (h) necrotic signal; (i) septations; (j) vascular signal void signal; (k) fat rim; and (l) hemorrhage; and according to (2) morphologic assessment: (a) lesion size (maximal diameter) in centimeters (cm); (b) lesion depth in cm; (c) margins; (d) peritumoral edema; (e) bone involvement; (f) marginal capsule or pseudocapsule; and (g) neurovascular bundle involvement. Univariate and multivariate analyses followed by stepwise logistic regression of combination of imaging features were performed. The predictive value of each imaging feature and various combinations of imaging features were determined. RESULTS: In univariate analysis, T2 low signal matrix, fibrous tissue, calcification, necrosis, septum, fat rim sign, peritumoral edema, and hemorrhage showed statistically significant differences between benign and malignant masses (p < 0.05). The positive predictive value of necrosis for malignancy was 84.8%, and its specificity was 90.9%. In multivariate analysis, the best model for predicting malignant masses was the combination of necrosis, maximal mass diameter, peritumoral edema, and absent fibrosis, absent calcification, and lack of fat rim. The combination of these parameters resulted in the most correct diagnoses of malignancy, with a sensitivity of 84.2%, specificity of 64.0%, and accuracy of 74.8%, whereas the accuracy of models consisting of component character and morphologic feature were 74.3% and 70.9%, respectively. CONCLUSION: MRI is useful in determining whether a soft tissue mass is malignant or not. Traditional morphologic assessment was reinforced by detailed component characterization analysis. The parameters favoring malignancy were large lesion size, peritumoral edema, necrosis, and absent calcification, absent fibrosis, and lack of fat rim.
BACKGROUND: There is a variable degree of accuracy in discriminating benign from malignant soft tissue masses based on signal intensity and morphologic characteristics by magnetic resonance imaging (MRI). The aim of this study was to determine the utility of detailed component pattern assessment, in addition to morphologic study, for differentiating benign from malignant soft tissue masses by MRI. METHODS: The imaging features of 118 histologically proven soft tissue masses were analyzed according to: (1) signal characteristics: (a) high T1 matrix; (b) low T2 matrix; (c) fibrous tissue signal; (d) calcification; (e) myxoid signal tissue; (f) fatty signal tissue; (g) cystic signal; (h) necrotic signal; (i) septations; (j) vascular signal void signal; (k) fat rim; and (l) hemorrhage; and according to (2) morphologic assessment: (a) lesion size (maximal diameter) in centimeters (cm); (b) lesion depth in cm; (c) margins; (d) peritumoral edema; (e) bone involvement; (f) marginal capsule or pseudocapsule; and (g) neurovascular bundle involvement. Univariate and multivariate analyses followed by stepwise logistic regression of combination of imaging features were performed. The predictive value of each imaging feature and various combinations of imaging features were determined. RESULTS: In univariate analysis, T2 low signal matrix, fibrous tissue, calcification, necrosis, septum, fat rim sign, peritumoral edema, and hemorrhage showed statistically significant differences between benign and malignant masses (p < 0.05). The positive predictive value of necrosis for malignancy was 84.8%, and its specificity was 90.9%. In multivariate analysis, the best model for predicting malignant masses was the combination of necrosis, maximal mass diameter, peritumoral edema, and absent fibrosis, absent calcification, and lack of fat rim. The combination of these parameters resulted in the most correct diagnoses of malignancy, with a sensitivity of 84.2%, specificity of 64.0%, and accuracy of 74.8%, whereas the accuracy of models consisting of component character and morphologic feature were 74.3% and 70.9%, respectively. CONCLUSION: MRI is useful in determining whether a soft tissue mass is malignant or not. Traditional morphologic assessment was reinforced by detailed component characterization analysis. The parameters favoring malignancy were large lesion size, peritumoral edema, necrosis, and absent calcification, absent fibrosis, and lack of fat rim.
Authors: E Sala; E Mema; Y Himoto; H Veeraraghavan; J D Brenton; A Snyder; B Weigelt; H A Vargas Journal: Clin Radiol Date: 2016-10-11 Impact factor: 2.350
Authors: Amani Arthur; Edward W Johnston; Jessica M Winfield; Matthew D Blackledge; Robin L Jones; Paul H Huang; Christina Messiou Journal: Front Oncol Date: 2022-07-01 Impact factor: 5.738
Authors: Pedro Augusto Gondim Teixeira; Frederique Gay; Bailiang Chen; Marie Zins; François Sirveaux; Jacques Felblinger; Alain Blum Journal: Skeletal Radiol Date: 2015-12-01 Impact factor: 2.199
Authors: Felix G Gassert; Florian T Gassert; Katja Specht; Carolin Knebel; Ulrich Lenze; Marcus R Makowski; Rüdiger von Eisenhart-Rothe; Alexandra S Gersing; Klaus Woertler Journal: BMC Cancer Date: 2021-01-22 Impact factor: 4.430
Authors: Armanda De Marchi; Simona Pozza; Lorena Charrier; Filadelfo Cannone; Franco Cavallo; Alessandra Linari; Raimondo Piana; Irene Geniò; Paolo Balocco; Alessandro Massè Journal: Int J Environ Res Public Health Date: 2020-11-28 Impact factor: 3.390